News
on
|
Research Feature
Multi-institute NIH study suggests that the HPV vaccine could protect women against new HPV infections after stem cell transplantation The human papillomavirus (HPV) vaccine provides a safe, robust immune response against HPV in reproductive-aged women who have had a stem cell transplant. The results from the small study published in the Journal of...
|
News Release
Fresh red blood cell transfusions do not help critically ill children more than older cells NIH-funded finding may alter policies at hospitals where fresh red cells are preferentially used Researchers have found that transfusions using fresh red blood cells—cells that have spent seven days or less in storage—are no more beneficial than older red...
|
News Release
Initial investment aims to advance accessible and scalable candidate interventions into clinical trials within 10 years The National Institutes of Health plans to invest at least $100 million over the next four years toward an audacious goal: develop affordable, gene-based cures for sickle cell disease (SCD) and HIV. The Bill & Melinda Gates...
|
Research Feature
En el 2000, Mercy Mendoza, a los 3 años, languidecía con una enfermedad misteriosa. Su abuela, desesperanzada, compró un sitio donde enterrarla en el pueblito de Honduras donde vivían. La hinchazón, el dolor y la inmovilidad estaban erosionando rápidamente su salud. Finalmente, un médico que había estudiado en los Estados Unidos reconoció su...
|
Research Feature
In 2000, a mysterious disease was making 3-year-old Mercy Mendoza so ill that her grandmother bought a burial plot for her in the little town in Honduras where they lived. Swelling, pain, and immobility were fast eroding her health. Finally, a doctor who had been trained in the United States recognized her condition: It was sickle cell disease, an...
|
Research Feature
When CBS’s 60 Minutes aired the compelling story of a Florida woman whose severe sickle cell disease symptoms were alleviated with a cutting edge gene therapy technique, people listened. A lot of them. The treatment happened at the National Institutes of Health, and since the showcasing of its dramatic success, NIH has been responding to scores of...
|
Research Feature
A conversation with Dr. Kolapo Oyebola It is not lost on Kolapo Oyebola, Ph.D., that half the sickle cell disease cases worldwide can be found in his native Nigeria. This tragic fact, said the National Institutes of Health (NIH) postdoctoral fellow, has long been top of mind—and he is bent on doing something about it. Something big. He wants to...